Abstract:The poor therapy response and poor prognosis of esophageal cancer has made it one of the most malignant carcinoma, and the complicated multidisciplinary treatment failed to achieve a long-term disease-free survival. To diagnose esophageal cancer at an earlier stage, and to improve the effect of anticancer therapy would improve the therapeutic efficacy. After retrospective analysis of the cancer samples of patients who received esophagectomy, we found the relevance between ratio of either ALDH1 or CD133-positive cancer stem cells and 2-year recurrence. Higher ratios of cancer stem cells indicated later clinical stages, and Wnt signaling activation was more frequent in later esophageal carcinoma. Further in bench studies, we explored the suppressive roles and the mechanisms involved in Let‑7 on self-renewal in ECA‑109 and ECA‑9706 esophageal cancer stem cells. Isolated cancer stem cells naturally divide symmetrically and are therapy resistant. Therapy of fluorouracil and docetaxel both enriched the stem cells, proving the resistant characteristics of cancer stem cells. Wnt activation stimulated more symmetric division of stem cells, resulting in self-renewal promotion, which could be blocked by Let‑7 overexpression. Furthermore, enforced Let‑7 sensitized the stem cells to chemotherapies in a Wnt pathway inhibition-dependent manner, contributing to Let‑7 sensitization of chemotherapeutic response. Wnt activation weakened the suppressive Let‑7b through the sponge functions of CCAT-1, forming the negative feedback loop of Let‑7b/Wnt/CCAT1. These results identified the crucial participation of stem cells in esophageal cancer occurrence and progression as the potent indicator, and also indicate the potential powerful agent of Let‑7 nano-particles in treatment of cancer.

Possible Carcinogenesis of Tumor Suppressor Let-7

Advances in Research of Let-7 in Cancer

MicroRNA Let-7C Inhibits Cell Proliferation and Induces Cell Cycle Arrest by Targeting CDC25A in Human Hepatocellular Carcinoma

Let-7c Microrna Expression and Clinical Significance in Hepatocellular Carcinoma.

Microrna Let-7g and Let-7i Inhibit Hepatoma Cell Growth Concurrently Via Downregulation of the Anti-Apoptotic Protein B-Cell Lymphoma-Extra Large

The Roles of the Let-7 Family of MicroRNAs in the Regulation of Cancer Stemness

The Insights of Let-7 Mirnas in Oncogenesis and Stem Cell Potency.

Pivotal Role Of Reduced Let-7g Expression In Breast Cancer Invasion And Metastasis

Let-7: a Regulator of the ERα Signaling Pathway in Human Breast Tumors and Breast Cancer Stem Cells.

Let-7a regulates mammosphere formation capacity through Ras/NF-κB and Ras/MAPK/ERK pathway in breast cancer stem cells.

MicroRNA Let-7C-5p Alleviates in Hepatocellular Carcinoma by Targeting Enhancer of Zeste Homolog 2: A Study Intersecting Bioinformatic Analysis and Validated Experiments

Let-7a Regulates Mammosphere Formation Capacity Through Ras/NF-κB and Ras/MAPK/ERK Pathway in Breast Cancer Stem Cells

Let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells

Data from Pivotal Role of Reduced <i>let-7g</i> Expression in Breast Cancer Invasion and Metastasis

Breast cancer stem-like cells are sensitized to tamoxifen induction of self-renewal inhibition with enforced Let-7c dependent on Wnt blocking

Data from the &Lt;i>let-7&Lt;/i> MicroRNA Represses Cell Proliferation Pathways in Human Cells

Let-7c Blocks Estrogen-Activated Wnt Signaling in Induction of Self-Renewal of Breast Cancer Stem Cells.

MicroRNA expression profile of colon cancer stem-like cells in HT29 adenocarcinoma cell line.

Let-7c inhibits cholangiocarcinoma growth but promotes tumor cell invasion and growth at extrahepatic sites

Nano Let-7b Sensitization of Eliminating Esophageal Cancer Stem-Like Cells is Dependent on Blockade of Wnt Activation of Symmetric Division

MicroRNA-7: a promising new target in cancer therapy